Research Article

Resection of Nonalcoholic Steatohepatitis-Associated Hepatocellular Carcinoma: A Western Experience

Table 2

Surgical series of NASH-associated HCCs (≥5 patients).

nAge (years)Gender (M : F)Tumor size (cm)Primary Tx Cirrhosis (%)Recurrence (%)

Hashizume et al. [15]971.5**6 : 33.8*LR 67%,
RFA 22%,
TAE 11%
6711.1
Kawada et al. [16]673**3 : 33.5**LR 100%0N.R.
Malik et al. [17]1763.1*12 : 53.4*LT 100%1005.9
Tokushige et al. [18]16N.R.N.R.N.R.LR 81%,
RFA 18%
N.R.88
Takuma and Nouso [19]1173.8*6 : 53.3*LR 64%,
RFA 27%,
MCT 9%
3660a

LR: liver resection, RFA: radiofrequency ablation, TAE: transarterial embolization, LT: liver transplant, MCT: microwave coagulation therapy.
*Mean, **median, arecurrence-free survival.